High materiality9/10
CBIO insider buy by Fairmount Funds Management LLC
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
bullish
What happened, with direct paths to the underlying reporting
Fairmount Funds Management LLC reported a buy in CBIO worth about $12,375,025.
Insider: Fairmount Funds Management LLC
Role: director, 10 percent owner:
Transaction: P-Purchase
Shares: 853,450
Price: $14.5
Value: $12,375,025
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.